Sanofi

SNYNF | OTC

Price Alert Chart Builder DCF Calculator

$85.35

+$1.46 (+1.74%)

Sep 21, 2026, 4:00 PM ET · Market open

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021	Q4 2020 Dec 30, 2020	Q3 2020 Sep 29, 2020	Q2 2020 Jun 29, 2020	Q1 2020 Mar 30, 2020
Revenue	46.92B	44.95B	45.47B	40.91B	39.45B	41.36B	41.11B	45.7B	46.14B	46.2B	45.39B	44.35B	42.04B	40.34B	39.18B	38.5B	37.55B	36.94B	37.37B	37.65B	37.69B	38.23B
Cost of Revenue	12.24B	17.17B	17.72B	24.51B	24.27B	19.61B	19.25B	13.92B	13.91B	13.89B	13.7B	13.44B	12.84B	12.45B	12.25B	12.22B	12.16B	11.98B	12.16B	12.18B	12.13B	12.22B
Gross Profit	33.38B	38.92B	38.88B	44.85B	43.64B	37.77B	37.88B	31.78B	32.23B	32.31B	31.69B	30.91B	29.2B	27.89B	26.92B	26.28B	25.39B	24.96B	25.21B	25.47B	25.56B	26.01B
Operating Income	8.58B	8.42B	7.59B	7.95B	7.52B	8.06B	9.08B	9.48B	9B	8.57B	8.5B	8.03B	8.35B	8.47B	8.13B	8.16B	7.74B	14.24B	14.23B	12.6B	12.12B	3.76B
Interest Income	332M	348M	413M	-34M	-24M	9M	19M	584M	493M	392M	241M	96M	46M	38M	42M	39M	113M	105M	114M	125M	78M	112M
Pretax Income	8.32B	7.98B	7.09B	4.85B	4.3B	4.96B	6.1B	9.2B	8.83B	8.41B	8.27B	7.74B	8.02B	8.15B	7.8B	7.82B	7.32B	13.81B	13.81B	12.2B	11.8B	3.44B
Net Income	9.31B	6.48B	5.74B	4.51B	4.22B	4.54B	5.4B	7.42B	6.97B	6.71B	6.72B	6.39B	6.63B	6.67B	6.22B	6.17B	5.81B	12.2B	12.31B	11.22B	11.04B	3.35B
Selling & General & Admin	8.78B	11.41B	11.29B	15.56B	15.46B	12.78B	13.27B	10.66B	10.72B	10.72B	10.49B	10.36B	9.98B	9.74B	9.56B	9.4B	9.31B	9.24B	9.39B	9.53B	9.66B	9.85B
Research & Development	7.69B	9.2B	9.11B	10.53B	10.34B	8.55B	8.39B	6.68B	6.75B	6.78B	6.71B	6.47B	6.18B	5.91B	5.69B	5.62B	5.5B	5.46B	5.53B	5.7B	5.74B	5.97B
Other Expenses	6.46B	4.73B	5.73B	4.3B	2.4B	2.4B	-88M	-321M	-316M	-440M	-370M	-138M	-147M	-23M	-5M	-4M	n/a	n/a	120M	187M	130M	130M
Operating Expenses	22.93B	25.34B	26.14B	30.4B	29.36B	25.93B	24.66B	20.97B	20.23B	20.19B	19.81B	19.58B	19.3B	18.4B	17.77B	17.29B	17.08B	16.97B	17.41B	17.78B	17.91B	18.4B
Interest Expense	661M	709M	749M	675M	728M	795M	710M	868M	653M	552M	472M	385M	369M	380M	391M	399M	312M	300M	299M	289M	398M	436M
Selling & Marketing Expenses	4.51B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.6B	2.6B	4.87B	7.21B	7.34B	9.66B	9.85B
Cost & Expenses	38.34B	36.53B	37.88B	32.97B	31.69B	32.76B	31.13B	34.89B	34.14B	34.09B	33.51B	33.01B	32.14B	30.85B	30.03B	29.51B	29.24B	28.95B	29.57B	29.95B	30.04B	30.62B
Income Tax Expense	1.64B	1.71B	1.39B	2.07B	1.9B	1.87B	2.17B	1.7B	1.74B	1.63B	1.5B	1.36B	1.37B	1.49B	1.56B	1.62B	1.5B	1.78B	1.81B	1.34B	1.12B	318M
Shares Outstanding (Basic)	1.23B	1.23B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.25B	1.26B	1.25B	1.25B
Shares Outstanding (Diluted)	1.23B	1.23B	1.25B	1.25B	1.25B	1.25B	1.26B	1.25B	1.25B	1.25B	1.26B	1.25B	1.25B	1.25B	1.25B	1.25B	1.26B	1.25B	1.26B	1.26B	1.26B	1.25B
EPS (Basic)	7.36	5.06	4.45	3.61	3.37	5.22	5.91	7.52	7.17	5.37	5.38	5.11	5.29	6.57	6.21	6.17	5.88	11.07	11.17	10.30	10.16	2.68
EPS (Diluted)	7.36	4.89	4.28	3.44	3.20	5.21	5.90	7.50	7.15	5.36	5.37	5.11	5.29	6.56	6.20	6.16	5.87	11.04	11.14	10.27	10.13	2.68
EBITDA	9.47B	11.64B	11.03B	10.89B	10.56B	8.98B	9.93B	12.22B	11.76B	11.92B	11.67B	10.89B	11.02B	10.67B	10.27B	10.41B	10.26B	16.48B	16.54B	16.62B	15.86B	7.66B
EBIT	8B	8.22B	7.45B	6.83B	6.41B	6.62B	7.64B	12.16B	11.59B	11.11B	10.89B	8.16B	8.41B	8.55B	8.21B	8.19B	7.77B	14.25B	14.25B	12.65B	12.2B	3.87B
Depreciation & Amortization	1.47B	3.42B	3.59B	4.06B	4.15B	3.67B	3.6B	4.52B	4.42B	4.39B	4.35B	4.37B	4.29B	4.2B	4.14B	4.18B	4.62B	4.91B	4.98B	6.99B	6.68B	5.22B